FIELD: chemistry.
SUBSTANCE: invention relates to biotechnology, specifically obtaining immunogens from Neisseria meningitides and can be used in medicine. Disclosed is protein which is 80% or more identical to amino acid sequence SEQ ID NO:19, and an immunogenic composition with said protein.
EFFECT: invention enables to use said protein for effective prevention or treatment of bacterial meningitis.
6 cl, 5 dwg, 28 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| HYBRID EXPRESSION OF NEISSERIA PROTEINS | 2001 |
|
RU2304617C2 |
| HETEROLOGOUS EXPRESSION OF NEISSERIA PROTEINS | 2001 |
|
RU2299906C2 |
| LIQUID VACCINES FOR MULTIPLE MENINGOCOCCAL SEROGROUPS | 2004 |
|
RU2378010C2 |
| POLYPEPTIDE VACCINES FOR WIDE PROTECTION AGAINST ROWS OF MENINGOCOCCUS GENERATIONS WITH INCREASED VIRULENCE | 2003 |
|
RU2333007C2 |
| LIQUID VACCINE FOR MULTIPLE SEROGROUPS OF MENINGOCOCCUS | 2009 |
|
RU2595845C2 |
| COMPOSITIONS OF MENINGOCOCCAL VACCINES WITH ADJUVANTS | 2002 |
|
RU2360699C2 |
| HYBRID AND TANDEM EXPRESSION OF NEISSERIA PROTEINS | 2002 |
|
RU2339646C2 |
| VACCINES CONTAINING ALUMINIUM ADJUVANTS AND HISTIDIN | 2007 |
|
RU2432173C2 |
| VACCINES COMPRISING ALUMINUM ADJUVANTS AND HISTIDINE | 2002 |
|
RU2323002C2 |
| MULTIPLE VERSIONS OF MENINGOCOCCAL PROTEIN NMB 1870 | 2003 |
|
RU2336091C2 |
